Targeting Treg signaling for the treatment of autoimmune diseases - Wikidata - wikimedia - TriplyDB

Targeting Treg signaling for the treatment of autoimmune diseases

Targeting Treg signaling for the treatment of autoimmune diseases

http://www.wikidata.org/entity/Q36372616

about

Bee Venom Phospholipase A2: Yesterday's Enemy Becomes Today's Friend Peripherally Induced Regulatory T Cells: Recruited Protectors of the Central Nervous System against Autoimmune Neuroinflammation.Global Regulatory T-Cell Research from 2000 to 2015: A Bibliometric Analysis.Interleukin-37 Enhances the Suppressive Activity of Naturally Occurring CD4+CD25+ Regulatory T Cells.The future of multiple sclerosis treatments.Empowering Regulatory T Cells in Autoimmunity.Impact of Immune-Modulatory Drugs on Regulatory T Cell.MicroRNA-22-3p as a novel regulator and therapeutic target for autoimmune diseases.The multiple pathways to autoimmunity.Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine.Phosphoproteomics Reveals Regulatory T Cell-Mediated DEF6 Dephosphorylation That Affects Cytokine Expression in Human Conventional T Cells.Ectopic Expression of Self-Antigen Drives Regulatory T Cell Development and Not Deletion of Autoimmune T Cells.An Autocrine TNFα-Tumor Necrosis Factor Receptor 2 Loop Promotes Epigenetic Effects Inducing Human Treg Stability In Vitro.Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3.Regulatory T Cells in Systemic Sclerosis

P2860

Q26767063-3562995C-AA7A-4F3B-B27E-825300ED61D0 Q33650505-C307A5AA-1F5C-4DDD-9D15-564C1BFEA00A Q36127999-236AF81B-CB74-450C-9296-CB41BB5474D2 Q37492932-0C95B554-8EFE-4A58-B836-E16A4240DD86 Q38808485-E1DC3056-F243-44E2-B46D-CCB51341F218 Q38909420-5A4337D8-8D31-43F2-9A89-D0B6D64D32A5 Q38918124-F4B9F553-32C3-4DE3-92E3-C491E4644743 Q39282997-D0C716E2-F1FE-4840-983E-05436612E3EA Q39386100-048A8325-EEDA-412C-BA7D-2E11E3733168 Q41718001-68C355CD-A2A4-4DDE-85A6-DE36C594027F Q41997359-85959A93-10EE-4D48-AD76-E293B555EB16 Q48186081-79F7C6D0-E7D2-47AD-8F02-B6E864BD8523 Q55027907-9B5EF0F6-E849-4459-AEFE-5B76D00DB86A Q55287352-0A7CFEA7-A83F-4DEF-B52E-A545B91960DA Q58122062-D9760780-E6FE-42D1-B6ED-83289E1562BD

P2860

Targeting Treg signaling for the treatment of autoimmune diseases

http://www.wikidata.org/entity/Q36372616

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Targeting Treg signaling for the treatment of autoimmune diseases

@ast

Targeting Treg signaling for the treatment of autoimmune diseases

@en

type

label

Targeting Treg signaling for the treatment of autoimmune diseases

@ast

Targeting Treg signaling for the treatment of autoimmune diseases

@en

prefLabel

Targeting Treg signaling for the treatment of autoimmune diseases

@ast

Targeting Treg signaling for the treatment of autoimmune diseases

@en

P1433

Q36372616-1799FF40-340D-4B7C-BF2B-1412D5EC25A0

P1476

Q36372616-67167DA3-9A67-4133-A205-71BEC300E91D

P2093

Q36372616-1E718E46-A100-4952-A302-34816630B582

Q36372616-423E3033-0454-4DC3-AD8E-455D5308CE99

Q36372616-BAF3F035-19A1-47A9-A966-E4021FC27371

Q36372616-C34885B0-DC08-4F70-856C-0935B4C95EDF

P2860

Q36372616-00DD9F56-170B-4F3C-940E-198F0C274FB9

Q36372616-02B21F20-1A3E-4BCC-A0FD-E992E9F7C1A4

Q36372616-038FBEB3-A4D1-43D0-95D3-881C2F7D0178

Q36372616-046FC48F-2EE5-48AC-B16B-59C3AC98F56D

Q36372616-04C31D9B-2760-4F05-A830-1471CB314640

Q36372616-06BE51CE-47FA-4C46-811A-66BCAB10A676

Q36372616-086146DC-477F-4DB5-8247-36988131DCF3

Q36372616-0941035B-6FEF-4237-AEB4-F1B202036A02

Q36372616-09D941B7-B82A-4BAC-8485-5507702945F8

Q36372616-0EC83150-7A56-4F4A-A1D3-0618A81E02A8

P304

Q36372616-5A4ED00B-B7BF-4372-9915-7FFCB0CE0B01

P31

Q36372616-B43BCC2F-3865-4156-B276-1E3ADFB7A789

P356

Q36372616-38F939B1-EFC0-4C1E-87AF-02CC8FCDCCCC

P478

Q36372616-B6EC8C34-C660-485E-B01C-68081CF29B2C

P577

Q36372616-8DFDCF47-9D10-40AD-87B7-D8D8D7721E72

P698

Q36372616-3E8F88E5-F620-4EB7-9DDB-9A6D00B25541

P932

Q36372616-21D54D46-B78F-47AB-A6AF-FF506CB03E29

P356

J.COI.2015.09.002

P1433

Current Opinion in Immunology

P1476

Targeting Treg signaling for the treatment of autoimmune diseases

@en

P2093

Allyson Spence

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Bluestone

http://www.w3.org/2001/XMLSchema#string

Joanna E Klementowicz

http://www.w3.org/2001/XMLSchema#string

Qizhi Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction

Regulatory T-cell therapy in transplantation: moving to the clinic

Synthetic Nanoparticles for Vaccines and Immunotherapy

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

The PI3K p110δ regulates expression of CD38 on regulatory T cells

FOXP3+ regulatory T cells in the human immune system

Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

Novel Foxo1-dependent transcriptional programs control T(reg) cell function

CD45 ligation expands Tregs by promoting interactions with DCs

P304

11-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.COI.2015.09.002

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26432763

http://www.w3.org/2001/XMLSchema#string

P932

4679451

http://www.w3.org/2001/XMLSchema#string